#NephPearls
LightNews LightNews
edgarvlermamd.medsky.network
Diagnosis of ADPKD remains radiological/ clinical in most cases
#Nephpearls #KidneyWk #NephSky

👉 pubmed.ncbi.nlm.nih.gov/40126492/
October 23, 2026 at 12:17 AM
edgarvlermamd.medsky.network
Among patients w/ IgA nephropathy #IgAN, treatment w/ sibeprenlimab stabilized the eGFR slope over 24 months, consistent w/ a reduced risk of kidney-function decline ca. 2026 from @nejm.org
#Nephpearls #KidneyWk #NephSky

Visual Abstract by @cristinapopa.bsky.social

👉 www.nejm.org/doi/full/10....
October 23, 2026 at 1:54 PM
edgarvlermamd.medsky.network
Trends in Mortality of Patients with Central Venous Catheters (CVC) vs Arteriovenous (AV) Accesses for Hemodialysis ca. 2026 from @asnpublications.bsky.social
#Nephpearls #VascularAccessPearls #KidneyWk #NephSky

👉 journals.lww.com/jasn/fulltex...
October 22, 2026 at 11:30 PM
edgarvlermamd.medsky.network
Point-of-care ultrasound #POCUS training in #nephrology: a position statement by the International Alliance for POCUS in Nephrology ca. 2024 from @nephrothaniel.bsky.social @myadla.bsky.social
#Nephpearls #KidneyWk #NephSky

👉 pubmed.ncbi.nlm.nih.gov/39502372/
October 21, 2026 at 2:39 PM
edgarvlermamd.medsky.network
SECONDS checklist for the interpretation of kidney ultrasound
#Nephpearls #NephSecrets #NephSky

👉 www.us.elsevierhealth.com/nephrology-s...
October 21, 2026 at 3:07 PM
edgarvlermamd.medsky.network
Going Beyond Survival: Kidney Transplantation in the Older Population ca. 2026 from @asnpublications.bsky.social
#Nephpearls #KidneyWk #NephSky

👉 www.kidneynews.org/view/journal...
👉 pubmed.ncbi.nlm.nih.gov/42173346/
October 21, 2026 at 10:48 PM
edgarvlermamd.medsky.network
More GDMT ≠ zero trade-offs
#Nephpearls #KidneyWk #NephSky

⚠️ In CKM, optimizing therapy can also mean navigating a higher risk of hyperkalemia

✅ The goal isn’t to back off - it’s to monitor, manage, and keep patients on the therapies that change outcomes

👉 pubmed.ncbi.nlm.nih.gov/42265997/
October 21, 2026 at 7:42 AM
edgarvlermamd.medsky.network
Primary Aldosteronism and the Kidneys ca. 2026 from @akdhjournal.bsky.social @hswapnil.medsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42397322/
October 19, 2026 at 1:07 PM
edgarvlermamd.medsky.network
Vascular endothelial growth factor inhibitor (VEGFi) induced hypertension ca. 2026 from @akdhjournal.bsky.social @gudnephron.bsky.social @sabinekaram.bsky.social @priti899.bsky.social
#Nephpearls #OncoNephrology 🦀 #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42405920/
October 19, 2026 at 3:10 PM
edgarvlermamd.medsky.network
If you're coming to @asnkidney.bsky.social
#KidneyWk do not miss this session
"Too Many Therapies for Diabetic Kidney Disease: What a Great Problem to Have!"
#Nephpearls #NephSky

🗓️ 25 Oct
⏰ 9:30 AM MDT
📍 Four Seasons Ballroom 1, Convention Center

👉 asn-online.org/education/ki...
October 15, 2026 at 1:53 PM
edgarvlermamd.medsky.network
Approach to hematuria ca. 2026 from @ajkd.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42767705/
October 11, 2026 at 2:22 AM
edgarvlermamd.medsky.network
PRO/CON debate: nonsteroidal (finerenone) vs. steroidal (spironolactone/ eplerenone) mineralocorticoid receptor antagonists in CKD: progress, pragmatism, and remaining uncertainties ca. 2026 from @ckj-era.bsky.social
#Nephpearls #Cardiorenal #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42682722/
October 10, 2026 at 12:25 PM
edgarvlermamd.medsky.network
C3G Glomerulopathy: Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org
#Nephpearls #NephSky

👉 kdigo.org/infographics/
October 7, 2026 at 12:53 PM
edgarvlermamd.medsky.network
IgA Nephropathy #IgAN: Pathophysiology and Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org
#Nephpearls #NephSky

👉 kdigo.org/infographics/
October 7, 2026 at 12:41 PM
edgarvlermamd.medsky.network
Select RCTs, informing current management strategies for patients with SA-AKI
#Nephpearls #AKIinICU #NephJC #NephSky

👉 shop.lww.com/Handbook-of-...
October 4, 2026 at 5:58 PM
edgarvlermamd.medsky.network
Sepsis is a syndrome defined by organ dysfunction because of a dysregulated host response to infection
#Nephpearls #AKIinICU #NephSky

📌 Septic shock is a subset of sepsis defined by hypotension requiring vasopressors to maintain an MAP >/= 65 mm Hg and serum lactate >2 mmol/L after resuscitation
October 4, 2026 at 4:52 PM
edgarvlermamd.medsky.network
Sepsis-associated AKI (SA-AKI): Pathophysiology
#Nephpearls #AKIinICU

📌 Organ dysfunction during sepsis develops even in the absence of decreased O2 delivery (Hypotension and ischemic injury are not the sole cause)

👉 pubmed.ncbi.nlm.nih.gov/36823168/
October 4, 2026 at 5:21 PM
edgarvlermamd.medsky.network
Treatment with maximally tolerated RAASi alone does not sufficiently slow the rate of eGFR decline in high-risk patients with IgA nephropathy #IgAN, leaving patients at risk of ESKD ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42584957/
October 3, 2026 at 12:38 AM
edgarvlermamd.medsky.network
Clinical conditions related to LVADs that may arise during hemodialysis
#Nephpearls #NephSky

👉 link.springer.com/book/10.1007...
September 30, 2026 at 11:03 PM
edgarvlermamd.medsky.network
Call 📢 for papers: "The Jerry Yee: Clinical Challenges in Diagnosis and Treatment in Nephrology"
#Nephpearls #NephSky

🗓️ Deadline for submissions: 15 October 2026

👉 www.sciencedirect.com/special-issu...
September 30, 2026 at 10:44 PM
edgarvlermamd.medsky.network
Ten tips for the diagnosis and management of nephrotic syndrome ca. 2026
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/42707999/
September 30, 2026 at 8:40 AM
edgarvlermamd.medsky.network
Impact of proteinuria levels on long-term kidney outcomes in IgA nephropathy: a meta-analysis ca. 2026 from @glomcon.org Rare Kidney Disease journal
#Nephpearls #NephSky

👉🏼 link.springer.com/article/10.1...
September 30, 2026 at 9:07 AM
edgarvlermamd.medsky.network
Not all #IgAN therapies are created equal
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/40928891/
September 26, 2026 at 6:43 PM
edgarvlermamd.medsky.network
Targeting B cells in immune-mediated kidney diseases: conclusions from @kdigo.org Controversies Conference ca. 2026
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/42034308/
September 26, 2026 at 5:13 PM
edgarvlermamd.medsky.network
Classic course of whole-kidney GFR and UAE according to the natural (proteinuric) pathway of #Diabetic #Kidney Disease (DKD) ca. 2017
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/28143897/
September 26, 2026 at 9:59 PM